Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Sakurai T et al. | 2009 | intact cell/cell culture, insulin-secreting cells | static magnetic field, MRI | 3–10 T |
Sakurai T et al. | 2012 | intact cell/cell culture, C2C12 cells (undifferentiated mouse myoblasts) | static magnetic field, DC, MRI | 3–10 T |
Okazaki R et al. | 2001 | animal, mouse/ICR, whole body: <i>in utero</i> | static magnetic field, MRI, co-exposure | 4.7 T |
Aldinucci C et al. | 2003 | intact cell/cell culture, Jurkat cells (human lymphoblastoid T cells) and human lymphocytes | static magnetic field, MRI | 4.75 T |
Ishizaki Y et al. | 2001 | bacterium, <i>Escherichia coli</i>/strain B (wild typ); KT1008 (<i>rpoS<sup>+</sup></i>); KT1005 (<i>rpoS::</i>TN<i>10</i>) | static magnetic field | 5.2 T |
Horiuchi S et al. | 2001 | bacterium, <i>Escherichia coli</i>/B | static magnetic field | 5.2 T |
Horiuchi S et al. | 2002 | intact cell/cell culture, <i>Escherichia coli</i>/B | static magnetic field | 5.2–6.1 T |
Nakamura K et al. | 1997 | bacterium, <i>Bacillus subtilis</i>/MI13 (normal or transformed with plasmid pC112 to enable the synthesis of surfactin (a cyclic lipopeptide antibiotic)) | static magnetic field, DC | 5.2–7 T |
Monzen S et al. | 2009 | intact cell/cell culture, CB CD34 cells (from human placental and umbilical cord blood) | static magnetic field | 5–10 T |
Iwasaka M et al. | 2004 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>) | static magnetic field | 5–14 T |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.